Phase
Condition
Myopic Macular Degeneration
Treatment
AAVB-039
Clinical Study ID
Ages 8-55 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Molecular diagnosis of Stargardt disease due to ABCA4 mutation
Willingness to adhere to protocol per informed consent
Exclusion
Exclusion Criteria:
Unwillingness to meet the requirements of the study
Participation in a clinical study with another Investigation Medicinal Product
Previous participation in another gene or cell therapy trial
Any condition that would preclude subretinal surgery
Complicating ocular and/or systemic diseases
Study Design
Connect with a study center
Moorfields Eye Hospital NHS Foundation Trust
London, England EC1V 2PD
United KingdomActive - Recruiting
The Retina Clinic
London, England W1G 9AX
United KingdomActive - Recruiting
The Retina Clinic
London 2643743, England 6269131 W1G 9AX
United KingdomActive - Recruiting
Associated Retina Consultants
Phoenix, Arizona 85020
United StatesActive - Recruiting
Retina Vitreous Associates Medical Group
Los Angeles, California 90211
United StatesActive - Recruiting
Mayo Clinic
Rochester, Minnesota 55905
United StatesActive - Recruiting
Retina Consultants of Texas
Bellaire, Texas 77401
United StatesActive - Recruiting
Retina Foundation of the Southwest
Dallas, Texas 75231
United StatesActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.